News

New Publication about structural bioinformatics analysis of SARS-CoV-2 variants

How does the binding affinity between SARS-CoV-2 spike receptor binding domain (RBD) and human receptor hACE2 change depending…

Innophore selected for Amazon Web Services (AWS) Diagnostic Development Initative

Press release – Innophore will receive credits and customized expertise from Amazon Web Service (AWS) to develop a…

JEDI Covid-19 GrandChallenge!

Our VirtualFlow team has made it to the finalist stage for the JEDI Covid-19 GrandChallenge! “An estimated 54…

Our next drug target-relevant Covid-19 paper is published as Scientific Reports from the Nature Group

Our next Covid-19 paper is published as Scientific Reports from the Nature Group https://www.nature.com/articles/s41598-021-83761-5 Abstract: Since the worldwide…

Coronavirus SARS-CoV-2 (formerly known as Wuhan coronavirus and 2019-nCoV) – what we can find out on a structural bioinformatics level

Christian C. Gruber*, Georg Steinkellner Innophore, Am Eisernen Tor 3, 8010 Graz, Austria * chirstian.gruber@innophore.com DISCLAIMER: Permission is…

Green computing for green processes

Innophore has put its new remotely operated hydropower data center into operation, deep in the heart of the…

Innophore & SignalChem start partnership

Innophore & SignalChem start partnership Innophore and SignalChem have agreed to collaborate on Drug & Enzyme Discovery in…

Meet us at the BIO-Europe Spring 2019 in Vienna!

Meet us in Vienna, at the BIO-Europe Spring on 25.03-27.03! This year’s event in Vienna will bring together the…

Meet us at the EuropeCEO 2019 in Vienna!

Meet us in Vienna, at the EuropeCEO on 24.03! The Europe CEO, a forum to network and share…

Thank you for your interest! Stay tuned!

Thank you for meeting us at the NOVEL ENZYMES 2018 Conference! Because of the overwhelming interest in our…